Reversal of experimental diabetic neuropathy by VEGF gene transfer

Journal of Clinical Investigation

Volumn 107, Issue 9, 2001, Pages 1083-1092

  Schratzberger, Peter ^a   Walter, Dirk H ^a   Rittig, Kilian ^a   Bahlmann, Ferdinand H ^a   Pola, Roberto ^a   Curry, Cynthia ^a   Silver, Marcy ^a   Krainin, Joseph G ^a   Weinberg, David H ^a   Ropper, Allan H ^a   Isner, Jeffrey M ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; LECTIN; STREPTOZOCIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; FEMALE; FLUORESCENCE; GENE OVEREXPRESSION; GENE TRANSFER; IMAGING; LASER DOPPLER FLOWMETRY; MOTOR NERVE CONDUCTION; NONHUMAN; PATHOGENESIS; PLASMID; PRIORITY JOURNAL; RABBIT; RAT; SENSORY NERVE CONDUCTION; TRANSGENE;

EID: 0035023584     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI12188     Document Type: Article

References (48)

1. Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors
2. Lower extremity foot ulcers and amputations in diabetes
3. Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions
4. Endothelial dysfunction and the expression of endothelial nitric oxide synthase in diabetic neuropathy, vascular disease, and foot ulceration
5. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
6. The epidemiology and cost of inpatient care of peripheral vascular disease, infection, neuropathy, and ulceration in diabetes
7. Glycation of rat sciatic nerve tubulin in experimental diabetes mellitus
8. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications
9. The relationship of vascular changes to metabolic factors in diabetic mellitus and their role in the development of peripheral nerve complications
10. Nerve growth factor administration protects against experimental diabetic sensory neuropathy
11. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy
12. Nerve blood flow in early experimental diabetes in rats: Relation to conduction deficits
13. Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: A novel technique of nerve photography and fluorescein angiography
14. Hypoxic neuropathy: Does hypoxia play a role in diabetic neuropathy
15. Nerve ischemia in diabetic rats: Time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models
16. Vascular endothelial growth factor is a secreted angiogenic mitogen
17. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
18. Rescue of diabetes related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF
19. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion
20. Age-dependent impairment of angiogenesis
21. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia
22. 165 following intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
23. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical results
24. 165
25. 165 as sole therapy for myocardial ischemia
26. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease
27. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia
28. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
29. Sensory and motor nerve conduction velocities and the latency of the H reflex during growth in rat
30. Org. 2766 improves functional and electrophysiological aspects of regenerating sciatic nerve in the rat
31. A mouse model of angiogenesis
32. Lectin histochemistry of mammalian endothelium
33. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
34. Vascular endothelial growth factor and diabetes: The agonist versus antagonist paradox
35. Favorable impact of VEGF gene transfer on ischemic peripheral neuropathy
36. Restoring lower limb blood flow improves conduction velocity in diabetic patients
37. Exercise-induced conduction velocity increment: A marker of impaired peripheral nerve blood flow in diabetic neuropathy
38. Microangiopathy in human diabetic neuropathy: Relationship between capillary abnormalities and the severity of neuropathy
39. Pentoxifylline effects on nerve conduction velocity and blood flow in diabetic rats
40. Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost
41. Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetics rats
42. Keeping in touch with angiogenesis
43. Vascular endothelial growth factor in ocular fluids of patients with diabetic retinopathy and other retinal disorders
44. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
45. Influence of vascular endothelial growth factor on diabetic retinopathy
46. Improvement in ischemic limb neuropathy after vegf gene transfer
47. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system
48. Vascular endothelial growth factor stimulates Schwann cell invasion and neovascularization of acellular nerve grafts